Qube Research & Technologies (QRT)
ABMD

Qube Research & Technologies (QRT)’s Abiomed Inc ABMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,463
Closed -$6.75M – 3183
2022
Q3 		$6.75M Buy
+27,463
New +$7.42M 0.04% 519
2021
Q4 		– Sell
-27,421
Closed -$8.93M – 3132
2021
Q3 		$8.93M Buy
+27,421
New +$9.29M 0.11% 221
2020
Q4 		– Sell
-13,942
Closed -$3.86M – 2313
2020
Q3 		$3.86M Sell
13,942
-10,070
-42% -$2.9M 0.06% 446
2020
Q2 		$5.8M Buy
24,012
+11,078
+86% +$2.22M 0.09% 304
2020
Q1 		$1.88M Sell
12,934
-37,470
-74% -$6.22M 0.08% 245
2019
Q4 		$8.6M Buy
+50,404
New +$9.34M 0.27% 58
2019
Q3 		– Sell
-1,851
Closed -$482K – 481
2019
Q2 		$482K Sell
1,851
-903
-33% -$240K 0.11% 184
2019
Q1 		$787K Sell
2,754
-223
-7% -$74.1K 0.1% 259
2018
Q4 		$968K Buy
2,977
+2,357
+380% +$819K 0.42% 45
2018
Q3 		$279K Sell
620
-178
-22% -$70.2K 0.04% 372
2018
Q2 		$326K Buy
+798
New +$289K 0.21% 105

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ABMD Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 27,463 shares — an estimated $6.75M sold.

Qube Research & Technologies (QRT) first reported a position in ABMD in Q2 2018 and held it in 11 quarters. The position peaked at $8.93M in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 27,463 Abiomed Inc shares in Q4 2022, an estimated $6.75M.
  • Qube Research & Technologies (QRT) first reported a position in Abiomed Inc in Q2 2018 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Abiomed Inc position peaked at $8.93M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.